GGrantIndex
Sort

51,593 grants matching hepatitis

Colorado Center for Childhood Liver Disease Research and Education

$1,128,188
Ronald J Sokol · University Of Colorado Denver · U01 · FY2012 · DK

The PIP2-virus interface and PI 4-kinase: novel biology and validation targets

$1,127,800
Jeffrey S Glenn · Stanford University · R01 · FY2012 · AI

Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models

$1,127,672
Ashley Brown · University Of Florida · R01 · FY2015 · AI

DCTD Human Toxicology and Pharmacology

$1,127,454
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA

Tracking HIV Infection & Alcohol Abuse CNS Comorbidity with Neuroimaging

$1,127,349
Adolf Pfefferbaum · Sri International · U01 · FY2018 · AA

Mechanisms of Liver Injury and Diseases

$1,127,253
Hartmut W Jaeschke · University Of Kansas Medical Center · P30 · FY2016 · GM

USC Research Center for Liver Disease

$1,127,105
Lucy Mary Golden · University Of Southern California · P30 · FY2020 · DK

Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care

$1,127,032
Bruce R Schackman · Weill Medical Coll Of Cornell Univ · P30 · FY2016 · DA

WADA (West Africa Database on Antiretroviral Therapy) Collaboration

$1,126,967
Francois Dabis · University Of Bordeaux Ii · U01 · FY2007 · AI

Regulation Of Immunopathology In Bacterial And Parasitic Disease

$1,126,913
Alan Sher · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

USC Research Center for Liver Disease

$1,126,655
Neil Kaplowitz · University Of Southern California · P30 · FY2013 · DK

Modeling human hepatotropic infections in complex tissue organoids

$1,126,288
Charles M. Rice · Rockefeller University · R01 · FY2010 · DK

Primary Cilia: A Novel Signaling Gateway To Neural Circuit Modulation

$1,126,098
Eva S Anton · Univ Of North Carolina Chapel Hill · R01 · FY2022 · MH

Reperfusion Injury Protection Strategies During Basic Life Support

$1,125,808
Demetris Yannopoulos · University Of Minnesota · R01 · FY2013 · HL

Preservation &Replacement of Beta Cells in IDDM

$1,125,182
Albert Einstein Col Of Med Yeshiva Univ · P01 · FY2004 · DK

IMPAACT 2041: PHASE I/II STUDY OF THE PHARMACOKINETICS AND SAFETY OF GLECAPREVIR/PIBRENTASVIR INITIATED IN PREGNANCY IN PEOPLE WITH HEPATITIS C WITH AND WITHOUT HIV

$1,125,154
Barbara Driver · Westat, Inc. · N01 · FY2025 · HD

Asian Community-Led Health Equity Structural Intervention (Asian CHESI)

$1,124,986
Dunli Wu · Asian Community Health Coalition · OT2 · FY2023 · OD

Integrating HCV services into HIV programs for PWID in India

$1,123,856
Shruti H Mehta · Johns Hopkins University · R01 · FY2020 · AI

NOX family NADPH oxidases: roles in innate immunity and inflammatory disease

$1,123,750
Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Center for Gastrointestinal Biology and Disease

$1,123,150
Robert S Sandler · Univ Of North Carolina Chapel Hill · P30 · FY2010 · DK

Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU

$1,122,839
Myron E Essex · Harvard School Of Public Health · UM1 · FY2017 · AI

Novel Therapies for Alcoholic Hepatitis

$1,122,111
Arthur J McCullough · Cleveland Clinic Lerner Com-Cwru · U01 · FY2012 · AA

Tracking HIV Infection & Alcohol Abuse CNS Comorbidity with Neuroimaging

$1,122,070
Adolf Pfefferbaum · Sri International · U01 · FY2020 · AA

Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy

$1,122,049
Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK

ER-shaping proteins of Plasmodium

$1,121,648
Purnima Bhanot · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI